SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

SNAP is trending following Q3 earnings and a new AI partnership with Perplexity, with the community weighing in on a potential short squeeze. Bullish investors highlight the potential for AI monetization and a turnaround narrative, while bears question the stock's ability to hold gains. Discussions also focus on a stock buyback program and potential upgrades following earnings.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo ($DUOL) is trending as investors debate the impact of AI on its business model after a recent price drop; discussions revolve around whether AI translation tools pose a significant threat to the language learning app's user base and revenue growth. Community members are analyzing the company's growth metrics, subscription numbers, and expansion into new areas like chess amid differing views on its long-term prospects. Some traders are also watching for a potential bounce, citing oversold conditions and strong underlying fundamentals.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc. is trending amid community discussions around its recent earnings report, with debates focusing on revenue growth, profitability, and valuation relative to competitors like Lemonade. While some investors express optimism about Root's long-term potential and strategic partnerships, others are concerned about slowing growth and potential market manipulation. The valuation gap between Root and competitors remains a key talking point.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending amid speculation around potential partnerships and analyst upgrades, with Oppenheimer setting a price target of $115. Community discussions revolve around the possibility of a tie-up with OpenAI and the stock's potential to reach new all-time highs, while some traders are wary of resistance levels and recent downgrades.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending as analysts raise price targets following strong Q3 revenue growth driven by its gaming business and early e-commerce platform success. The community is bullish, anticipating further gains and focusing on the potential of the AI-driven Axon platform, with some eyeing a retest of all-time highs, though there are concerns about valuation and regulatory scrutiny.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty ($ELF) is trending due to a recent analyst downgrade from Piper Sandler, citing concerns about growth and profitability despite the Rhode brand acquisition, causing a sharp stock drop and sparking debate among investors about its valuation. Some see the dip as a buying opportunity, pointing to the brand's Gen Z appeal and potential tariff benefits, while others express skepticism about its growth prospects and caution against investing in makeup companies amid technological advancements.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT) is trending as the community debates its potential amid accusations of competitor manipulation and a perceived battle between #base and #bnb chains. Discussions revolve around buybacks, locked developer tokens, and whether it is undervalued, with some calling for support from $COIN. Concerns about market manipulation and comparisons to similar tokens like $ASTER are prevalent.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors anticipate potential news, possibly a partnership or buyout, around the upcoming earnings call. Community discussions revolve around the possibility of a short squeeze, with some expressing frustration over the stock's performance and management's communication. Speculation about a potential deal with AstraZeneca is circulating, fueled by their aligned earnings call dates and a past real estate transaction.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy (SWEAT) is trending as community members express strong conviction that the token is undervalued and poised for a future breakout. Many users are emphasizing the long-term potential of SWEAT, highlighting its association with a health-focused app that rewards users for physical activity. Discussions also mention the upcoming opportunities with staking and potential for burning unclaimed tokens, possibly driving increased interest.

Energy Transfer LP engages in natural gas pipeline transportation and transmission services. It operates through the following segments: Intrastate Transportation and Storage, Interstate Transportation and Storage, Midstream, NGL and Refined Products Transportation and Services, Crude Oil Transportation and Services, Investment in Sunoco LP, Investment in USAC, and All Other. The Intrastate Transportation and Storage segment owns and operates natural gas transportation pipelines. The Interstate Transportation and Storage segment includes transportation pipelines, storage facilities, and gathering systems and delivery of natural gas to industrial end-users and other pipelines. The Midstream segment consists of natural gas gathering, compression, treating, processing, storage, and transportation. The NGL and Refined Products Transportation segment engages in the operations transport, store and execute acquisition, and marketing activities utilizing a complementary network of pipelines, storage and blending facilities, and strategic off-take locations that provide access to multiple NGL markets. The Crude Oil Transportation and Services segment provides transportation, terminalling, acquisition, and marketing services to crude oil markets. The Investment in Sunoco LP segment refers to the distribution of motor fuels to independent dealers, distributors, and other commercial customers and the distribution of motor fuels to end-user customers at retail sites. The Investment in USAC segment offers compression services to its customers in connection with infrastructure applications including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. The company was founded by Kelcy L. Warren in 1996 and is headquartered in Dallas, TX.

Energy Transfer LP - Unit

Energy Transfer LP Unit

Energy Transfer is trending due to discussions around its earnings report and future growth potential, particularly in supplying natural gas to data centers, highlighted by their deal with Oracle. Community members are weighing the company's long-term prospects against underwhelming recent results, debating debt refinancing, and anticipating analyst updates. Despite mixed reactions to earnings, the dividend yield remains a key talking point for investors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dynavax Technologies (DVAX) Surpasses Q3 Earnings Estimates

Dynavax Technologies (DVAX) delivered earnings and revenue surprises of +50.00% and -0.23%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates

Qiagen (QGEN) delivered earnings and revenue surprises of +5.17% and +1.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Nuvation Bio Inc. (NUVB) Reports Q3 Loss, Tops Revenue Estimates

Nuvation Bio (NUVB) delivered earnings and revenue surprises of +5.88% and +95.53%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025

Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025 Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025...

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial Dynavax Presents Positive Topline Data...

Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last?

Amgen (AMGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Dynavax Technologies Corp. (DVAX) on Thursday said that its experimental Shingles vaccine yielded positive results in an early-to-mid-stage study as compared to GSK Plc’s (GSK) Shingrix vaccine. &nbsp;Herpes zoster, or shingles, is a viral infection that affects approximately one in three people in their lifetime. The disease is characterized by a painful rash and can lead to serious complications, particularly in older adults.The company evaluated the experimental vaccine in participants aged 50 to 69 years for the first part of the study, and it showed that at one month after the second vaccine dose, Z-1018 <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.dynavax.com/news-releases/news-release-details/dynavax-announces-positive-topline-phase-12-results-supporting">demonstrated</a> immune responses similar to those observed in the arm receiving Shingrix with a favorable tolerability profile.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/DVAX">DVAX stock</a> jumped from ‘bearish’ to ‘bullish’ over the past 24 hours, while message volume rose from ‘normal’ to ‘high’ levels. Shares of the company traded 6% higher on Thursday afternoon at the time of writing.<figure class="image"><img style="aspect-ratio:569/59;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_21_at_2_08_19_PM_png_e38a9696ce.webp" alt="DVAX's Sentiment Meter and Message Volume as of 2:10 p.m. ET on Aug. 21, 2025 | Source: Stocktwits" width="569" height="59"><figcaption>DVAX's Sentiment Meter and Message Volume as of 2:10 p.m. ET on Aug. 21, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user suggested holding the stock patiently.<stembedurl>https://stocktwits.com/poorguy/message/626078462</stembedurl>The company said that it now intends to advance Z-1018 into the next part of the study in adults 70 years of age and older in the second half of the year. At the dose formulation and regimen chosen for advancing to the next part of the trial, Z-1018 achieved 100% antibody production compared to Shingrix at 96.9%, the company said.Furthermore, only 12.5% of participants receiving Z-1018 at the dose reported local post-injection reactions, compared to 52.6% for Shingrix, the company said. It also noted that 27.5% participants reported body-wide reactions with the experimental vaccine, compared to 63.2% in Shingrix."These positive data mark an important inflection point for our novel shingles vaccine program as we strive to develop a product with a potential best-in-class profile with the aim to disrupt the multi-billion-dollar shingles vaccine market, which is currently dominated by one product," said CEO Ryan Spencer, referring to Shingrix.DVAX stock is down by 14% this year and by about 3% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/nio-unveils-new-es8-starting-at-rmb-416800/chsj2ghRdiq">Nio Stock Rocketed 10% Today And Retail Believes It Could Hit The $10-Mark By Earnings – Find Out More</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Medical syringe is seen with Dynavax company logo displayed on a screen in the background in this illustration photo taken in Poland on June 16, 2020. (Photo Illustration by Jakub Porzycki/NurPhoto via Getty Images)

Dynavax’s Experimental Shingles Vaccine Shows Positive Results In Study: Retail Expects Stock Rally To Continue Into Friday

The company said that it now intends to advance Z-1018 into the next part of the study in adults 70 years of age and older in the second half of the year.

Equity

The company said that it now intends to advance Z-1018 into the next part of the study in adults 70 years of age and older in the second half of the year.


Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates

Dynavax Technologies (DVAX) delivered earnings and revenue surprises of +16.67% and +8.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Protagonist Therapeutics (PTGX) Reports Q2 Loss, Lags Revenue Estimates

Protagonist Therapeutics (PTGX) delivered earnings and revenue surprises of -3.77% and -46.67%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Exelixis (EXEL) Beats Q2 Earnings Estimates

Exelixis (EXEL) delivered earnings and revenue surprises of +15.38% and -1.84%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

DVAX
Dynavax Technologies Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DVAX News

DVAXDynavax Technologies Corp.